Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)] promotion: free to download

Volume:9   Issue:7
Pp: 789-790
Michele Caraglia and Daniele Santini
DOI: 10.2174/156800909789760429

Order Reprints Order Eprints

Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects

Volume:9   Issue:7
Pp: 791-800
M. Marra, A. Abbruzzese, R. Addeo, S. Del Prete, P. Tassone, G. Tonini, P. Tagliaferri, D. Santini and M. Caraglia
DOI: 10.2174/156800909789760285

Order Reprints Order Eprints

Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases

Volume:9   Issue:7
Pp: 834-842
D. Santini, M. E. Fratto, B. Vincenzi, N. Napoli, S. Galluzzo, M. Tantardini, A. Abbruzzese, M. Caraglia and G. Tonini
DOI: 10.2174/156800909789760375

Order Reprints Order Eprints

Targeted Therapies in Bone Sarcomas

Volume:9   Issue:7
Pp: 843-853
K. Scotlandi, P. Picci and H. Kovar
DOI: 10.2174/156800909789760410

Order Reprints Order Eprints

Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy

Volume:9   Issue:7
Pp: 854-870
P. Tassone, P. Tagliaferri, M. Rossi, T. Calimeri, A. Bulotta, A. Abbruzzese, M. Caraglia and P. Neri
DOI: 10.2174/156800909789760393

Order Reprints Order Eprints